Transcat (TRNS) Financials

$79.82 +0.17 (+0.21%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$80.50 +0.68 (+0.85%)

As of 04:31 AM Eastern

Annual Income Statements for Transcat

This table shows Transcat's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	3/26/2022	3/25/2023	3/30/2024
Net Income / (Loss) Attributable to Common Shareholders	11	11	14
Consolidated Net Income / (Loss)	11	11	14
Net Income / (Loss) Continuing Operations	11	11	14
Total Pre-Tax Income	13	13	18
Total Operating Income	14	16	20
Total Gross Profit	58	68	84
Total Revenue	205	231	259
Operating Revenue	205	231	259
Total Cost of Revenue	147	162	176
Operating Cost of Revenue	147	162	176
Total Operating Expenses	44	52	64
Selling, General & Admin Expense	24	27	35
Marketing Expense	21	25	29
Total Other Income / (Expense), net	-0.95	-2.76	-1.34
Interest Expense	0.81	2.42	1.84
Interest & Investment Income	0.00	0.00	0.81
Other Income / (Expense), net	-0.14	-0.34	-0.32
Income Tax Expense	1.81	2.80	4.79
Basic Earnings per Share	$1.52	$1.42	$1.66
Weighted Average Basic Shares Outstanding	7.50M	7.55M	8.24M
Diluted Earnings per Share	$1.50	$1.40	$1.63
Weighted Average Diluted Shares Outstanding	7.59M	7.65M	8.35M
Weighted Average Basic & Diluted Shares Outstanding	7.55M	7.64M	9.13M

This table shows Transcat's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	3/25/2023	6/24/2023	9/23/2023	12/23/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024
Net Income / (Loss) Attributable to Common Shareholders	3.07	2.36	1.60	3.66	2.95	0.46	3.35	6.89	4.41	3.29	2.36
Consolidated Net Income / (Loss)	3.07	2.36	1.60	3.66	2.95	0.46	3.35	6.89	4.41	3.29	2.36
Net Income / (Loss) Continuing Operations	3.07	2.36	1.60	3.66	2.95	0.46	3.35	6.89	4.41	3.29	2.36
Total Pre-Tax Income	3.45	3.09	2.12	4.83	3.76	0.80	4.27	9.60	5.23	3.71	3.13
Total Operating Income	3.60	3.63	3.16	5.86	4.64	1.64	4.29	9.20	5.10	3.74	2.10
Total Gross Profit	16	17	16	19	19	20	21	24	23	21	20
Total Revenue	55	56	57	62	61	63	65	71	67	68	67
Operating Revenue	55	56	57	62	61	63	65	71	67	68	67
Total Cost of Revenue	39	40	41	43	42	43	44	47	44	47	47
Operating Cost of Revenue	39	40	41	43	42	43	44	47	44	47	47
Total Operating Expenses	12	13	13	13	14	18	17	15	18	17	18
Selling, General & Admin Expense	6.61	7.24	6.64	6.85	7.60	12	9.12	6.97	9.76	9.29	9.46
Marketing Expense	5.82	5.90	6.60	6.45	6.47	6.86	7.52	7.87	7.80	8.18	8.12
Total Other Income / (Expense), net	-0.16	-0.54	-1.04	-1.03	-0.88	-0.84	-0.02	0.40	0.13	-0.02	1.03
Interest Expense	-	-	0.73	-	0.81	0.89	0.08	-	0.05	0.08	0.20
Interest & Investment Income	-	-	0.01	-	0.00	0.00	0.35	-	0.31	0.29	0.22
Other Income / (Expense), net	-0.16	-0.54	-0.31	0.66	-0.06	0.05	-0.29	0.88	-0.13	-0.23	1.01
Income Tax Expense	0.38	0.73	0.52	1.17	0.81	0.34	0.92	2.71	0.82	0.43	0.77
Basic Earnings per Share	$0.41	$0.31	$0.21	$0.49	$0.39	$0.06	$0.39	$0.82	$0.49	$0.36	$0.26
Weighted Average Basic Shares Outstanding	7.54M	7.55M	7.56M	7.55M	7.62M	7.82M	8.62M	8.24M	9.06M	9.16M	9.23M
Diluted Earnings per Share	$0.40	$0.31	$0.21	$0.48	$0.38	$0.06	$0.38	$0.81	$0.48	$0.35	$0.25
Weighted Average Diluted Shares Outstanding	7.63M	7.65M	7.67M	7.65M	7.76M	7.95M	8.75M	8.35M	9.20M	9.28M	9.33M
Weighted Average Basic & Diluted Shares Outstanding	7.55M	7.56M	7.56M	7.64M	7.69M	8.83M	8.83M	9.13M	9.15M	9.20M	9.31M

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	3/26/2022	3/25/2023	3/30/2024
Net Change in Cash & Equivalents	0.84	0.14	18
Net Cash From Operating Activities	18	17	33
Net Cash From Continuing Operating Activities	18	17	33
Net Income / (Loss) Continuing Operations	11	11	14
Consolidated Net Income / (Loss)	11	11	14
Depreciation Expense	9.57	11	14
Non-Cash Adjustments To Reconcile Net Income	2.45	3.54	4.97
Changes in Operating Assets and Liabilities, net	-5.78	-8.23	0.45
Net Cash From Investing Activities	-40	-19	-42
Net Cash From Continuing Investing Activities	-40	-19	-42
Purchase of Property, Plant & Equipment	-10	-9.41	-13
Acquisitions	-30	-9.11	-13
Purchase of Investments	0.00	0.00	-16
Sale of Property, Plant & Equipment	0.11	0.01	0.00
Net Cash From Financing Activities	24	0.88	27
Net Cash From Continuing Financing Activities	24	0.88	27
Repayment of Debt	-2.11	-2.12	-2.25
Repurchase of Common Equity	-6.68	-0.45	-4.91
Issuance of Debt	31	2.79	-43
Issuance of Common Equity	1.49	0.66	77
Other Net Changes in Cash	-0.63	0.82	-0.23
Cash Interest Paid	0.78	2.26	1.24
Cash Income Taxes Paid	3.90	1.12	3.10

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	3/25/2023	6/24/2023	9/23/2023	12/23/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024
Net Change in Cash & Equivalents	-0.95	0.47	0.68	-0.06	0.62	-0.90	34	-16	3.01	1.16	-19
Net Cash From Operating Activities	2.04	3.19	8.74	2.98	7.54	8.44	11	5.73	8.92	6.84	13
Net Cash From Continuing Operating Activities	2.04	3.19	8.74	2.98	7.54	8.44	11	5.73	8.92	6.73	13
Net Income / (Loss) Continuing Operations	3.07	2.36	1.60	3.66	2.95	0.46	3.35	6.89	4.41	3.29	2.36
Consolidated Net Income / (Loss)	3.07	2.36	1.60	3.66	2.95	0.46	3.35	6.89	4.41	3.29	2.36
Depreciation Expense	2.64	2.78	2.82	2.71	2.79	3.29	3.76	3.70	4.11	4.40	4.43
Non-Cash Adjustments To Reconcile Net Income	0.93	1.14	0.92	0.55	1.08	1.45	1.21	1.23	0.60	1.07	-0.37
Changes in Operating Assets and Liabilities, net	-4.60	-3.09	3.39	-3.94	0.72	3.24	2.59	-6.10	-0.20	-2.03	6.29
Net Cash From Investing Activities	-6.43	-2.37	-6.64	-3.07	-5.64	-13	-3.71	-20	-4.09	-3.86	-72
Net Cash From Continuing Investing Activities	-6.43	-2.37	-6.64	-3.07	-5.64	-13	-3.71	-20	-4.09	-3.86	-72
Purchase of Property, Plant & Equipment	-2.40	-2.37	-2.38	-2.27	-2.77	-2.68	-3.66	-4.18	-3.67	-3.96	-2.87
Acquisitions	-4.04	-	-4.27	-0.80	-2.87	-10	-0.05	0.07	-16	0.10	-70
Net Cash From Financing Activities	3.11	-0.82	-1.51	0.09	-0.86	3.17	27	-1.68	-1.94	-1.41	40
Net Cash From Continuing Financing Activities	3.11	-0.82	-1.51	0.09	-0.86	3.17	27	-1.68	-1.94	-1.41	40
Repayment of Debt	-0.49	-0.54	-0.54	-0.55	-0.55	-0.56	-43	-0.57	-0.58	-0.58	39
Repurchase of Common Equity	-0.44	-	-	-0.01	-0.30	-1.95	-	-2.66	-1.62	-1.41	-0.18
Issuance of Common Equity	0.22	0.14	0.14	0.16	0.20	0.19	75	1.55	0.26	0.58	0.93
Effect of Exchange Rate Changes	0.32	-	-	-	-	-	-	-	-	-	0.58
Cash Income Taxes Paid	0.12	0.37	0.47	0.16	0.11	0.99	0.79	1.22	0.06	5.47	1.33

This table presents Transcat's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	3/26/2022	3/25/2023	3/30/2024
Total Assets	178	196	288
Total Current Assets	60	68	105
Cash & Equivalents	1.40	1.53	20
Short-Term Investments	-	0.00	16
Accounts Receivable	40	45	48
Inventories, net	13	17	17
Prepaid Expenses	5.30	3.94	4.28
Plant, Property, & Equipment, net	26	29	39
Total Noncurrent Assets	92	99	143
Goodwill	65	69	106
Intangible Assets	15	14	20
Other Noncurrent Operating Assets	12	16	18
Total Liabilities & Shareholders' Equity	178	196	288
Total Liabilities	92	96	62
Total Current Liabilities	28	28	33
Short-Term Debt	2.16	2.25	2.34
Accounts Payable	14	16	11
Accrued Expenses	11	10	20
Total Noncurrent Liabilities	64	68	29
Long-Term Debt	46	47	1.82
Noncurrent Deferred & Payable Income Tax Liabilities	6.72	6.54	9.29
Other Noncurrent Operating Liabilities	11	14	18
Total Equity & Noncontrolling Interests	86	100	225
Total Preferred & Common Equity	86	100	225
Total Common Equity	86	100	225
Common Stock	28	32	146
Retained Earnings	59	69	80
Accumulated Other Comprehensive Income / (Loss)	-0.23	-1.20	-0.95

This table presents Transcat's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	6/24/2023	9/23/2023	12/23/2023	6/29/2024	9/28/2024	12/28/2024
Total Assets	182	187	188	203	248	281	324	324	386
Total Current Assets	59	63	61	64	65	99	94	95	77
Cash & Equivalents	0.44	0.91	1.59	2.15	1.25	35	23	24	4.64
Short-Term Investments	-	-	-	-	-	-	0.00	0.00	0.00
Accounts Receivable	38	41	38	43	45	44	48	50	52
Inventories, net	15	17	17	15	16	16	18	16	14
Prepaid Expenses	4.85	4.42	4.14	3.39	3.53	3.30	5.07	6.24	5.77
Plant, Property, & Equipment, net	27	28	28	30	36	37	46	47	50
Total Noncurrent Assets	96	96	99	110	147	145	183	181	259
Goodwill	67	66	69	77	106	106	138	138	177
Intangible Assets	16	15	15	15	23	21	26	24	58
Other Noncurrent Operating Assets	13	15	16	17	18	18	19	18	25
Total Liabilities & Shareholders' Equity	182	187	188	203	248	281	324	324	386
Total Liabilities	92	94	93	93	110	63	61	55	105
Total Current Liabilities	24	25	25	24	28	29	32	27	32
Short-Term Debt	2.18	2.21	2.23	2.27	2.29	2.32	2.36	2.39	2.41
Accounts Payable	-	14	14	12	13	11	13	13	16
Accrued Expenses	-	9.09	9.01	9.29	13	16	13	11	13
Total Noncurrent Liabilities	69	70	68	69	82	33	30	28	73
Long-Term Debt	50	49	47	46	51	2.41	1.22	0.61	39
Noncurrent Deferred & Payable Income Tax Liabilities	6.70	6.67	6.67	7.18	11	11	9.29	9.30	9.26
Other Noncurrent Operating Liabilities	12	14	14	16	20	20	19	18	24
Total Equity & Noncontrolling Interests	90	92	95	111	138	218	262	269	281
Total Preferred & Common Equity	90	92	95	111	138	218	262	269	281
Total Common Equity	90	92	95	111	138	218	262	269	281
Common Stock	29	30	31	40	68	145	180	184	195
Retained Earnings	62	64	66	72	71	74	84	86	88
Accumulated Other Comprehensive Income / (Loss)	-0.69	-1.52	-1.12	-0.72	-1.06	-0.69	-1.10	-0.72	-1.88

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric	2022	2023	2024
Period end date	3/26/2022	3/25/2023	3/30/2024
Growth Metrics	-	-	-
Revenue Growth	18.24%	12.50%	12.54%
EBITDA Growth	34.19%	13.97%	22.90%
EBIT Growth	40.25%	13.60%	22.40%
NOPAT Growth	41.19%	5.52%	13.70%
Net Income Growth	46.07%	-6.08%	27.69%
EPS Growth	45.63%	-6.67%	16.43%
Operating Cash Flow Growth	-25.47%	-3.79%	92.41%
Free Cash Flow Firm Growth	-636.89%	94.17%	-2,814.24%
Invested Capital Growth	30.57%	10.50%	31.88%
Revenue Q/Q Growth	3.60%	2.76%	3.53%
EBITDA Q/Q Growth	6.49%	6.37%	16.02%
EBIT Q/Q Growth	5.68%	10.91%	22.43%
NOPAT Q/Q Growth	-0.94%	9.73%	16.86%
Net Income Q/Q Growth	-1.39%	6.05%	31.03%
EPS Q/Q Growth	-1.32%	6.06%	25.38%
Operating Cash Flow Q/Q Growth	-13.51%	-11.78%	9.21%
Free Cash Flow Firm Q/Q Growth	-49.30%	89.19%	0.97%
Invested Capital Q/Q Growth	10.22%	3.05%	3.27%
Profitability Metrics	-	-	-
Gross Margin	28.51%	29.65%	32.30%
EBITDA Margin	11.50%	11.65%	12.72%
Operating Margin	6.90%	7.05%	7.62%
EBIT Margin	6.83%	6.90%	7.50%
Profit (Net Income) Margin	5.55%	4.64%	5.26%
Tax Burden Percent	86.28%	79.25%	74.01%
Interest Burden Percent	94.21%	84.80%	94.72%
Effective Tax Rate	13.72%	20.75%	25.99%
Return on Invested Capital (ROIC)	10.37%	9.18%	8.58%
ROIC Less NNEP Spread (ROIC-NNEP)	8.15%	4.56%	-3.42%
Return on Net Nonoperating Assets (RNNOA)	3.74%	2.32%	-0.17%
Return on Equity (ROE)	14.11%	11.50%	8.40%
Cash Return on Invested Capital (CROIC)	-16.15%	-0.79%	-18.92%
Operating Return on Assets (OROA)	9.04%	8.52%	8.06%
Return on Assets (ROA)	7.34%	5.72%	5.65%
Return on Common Equity (ROCE)	14.11%	11.50%	8.40%
Return on Equity Simple (ROE_SIMPLE)	13.21%	10.73%	6.06%
Net Operating Profit after Tax (NOPAT)	12	13	15
NOPAT Margin	5.95%	5.58%	5.64%
Net Nonoperating Expense Percent (NNEP)	2.22%	4.62%	11.99%
Cost of Revenue to Revenue	71.49%	70.35%	67.70%
SG&A Expenses to Revenue	11.54%	11.86%	13.61%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.61%	22.60%	24.67%
Earnings before Interest and Taxes (EBIT)	14	16	19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	24	27	33
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	6.48	6.59	4.37
Price to Tangible Book Value (P/TBV)	87.08	39.84	9.88
Price to Revenue (P/Rev)	2.72	2.85	3.79
Price to Earnings (P/E)	49.05	61.40	72.09
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	2.04%	1.63%	1.39%
Enterprise Value to Invested Capital (EV/IC)	4.54	4.78	4.91
Enterprise Value to Revenue (EV/Rev)	2.95	3.05	3.67
Enterprise Value to EBITDA (EV/EBITDA)	25.68	26.21	28.86
Enterprise Value to EBIT (EV/EBIT)	43.23	44.26	48.95
Enterprise Value to NOPAT (EV/NOPAT)	49.60	54.66	65.08
Enterprise Value to Operating Cash Flow (EV/OCF)	34.35	41.52	29.21
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.56	0.49	0.02
Long-Term Debt to Equity	0.54	0.47	0.01
Financial Leverage	0.46	0.51	0.05
Leverage Ratio	1.92	2.01	1.49
Compound Leverage Factor	1.81	1.70	1.41
Debt to Total Capital	35.99%	33.02%	1.81%
Short-Term Debt to Total Capital	1.61%	1.51%	1.02%
Long-Term Debt to Total Capital	34.38%	31.51%	0.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.01%	66.98%	98.19%
Debt to EBITDA	2.06	1.83	0.13
Net Debt to EBITDA	2.00	1.77	-0.94
Long-Term Debt to EBITDA	1.96	1.75	0.06
Debt to NOPAT	3.97	3.81	0.28
Net Debt to NOPAT	3.86	3.70	-2.12
Long-Term Debt to NOPAT	3.79	3.64	0.12
Altman Z-Score	5.75	6.28	11.28
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.15	2.39	3.14
Quick Ratio	1.50	1.65	2.49
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-19	-1.11	-32
Operating Cash Flow to CapEx	175.43%	180.25%	245.60%
Free Cash Flow to Firm to Interest Expense	-23.45	-0.46	-17.60
Operating Cash Flow to Interest Expense	21.75	7.01	17.77
Operating Cash Flow Less CapEx to Interest Expense	9.35	3.12	10.54
Efficiency Ratios	-	-	-
Asset Turnover	1.32	1.23	1.07
Accounts Receivable Turnover	5.49	5.39	5.55
Inventory Turnover	12.04	10.95	10.23
Fixed Asset Turnover	8.43	8.31	7.63
Accounts Payable Turnover	11.08	10.80	12.84
Days Sales Outstanding (DSO)	66.49	67.67	65.75
Days Inventory Outstanding (DIO)	30.33	33.35	35.68
Days Payable Outstanding (DPO)	32.94	33.80	28.43
Cash Conversion Cycle (CCC)	63.88	67.23	73.01
Capital & Investment Metrics	-	-	-
Invested Capital	133	147	194
Invested Capital Turnover	1.74	1.64	1.52
Increase / (Decrease) in Invested Capital	31	14	47
Enterprise Value (EV)	605	704	953
Market Capitalization	558	656	984
Book Value per Share	$11.46	$13.18	$25.50
Tangible Book Value per Share	$0.85	$2.18	$11.28
Total Capital	135	149	229
Total Debt	48	49	4.16
Total Long-Term Debt	46	47	1.82
Net Debt	47	48	-31
Capital Expenditures (CapEx)	10	9.40	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	33	40	39
Debt-free Net Working Capital (DFNWC)	34	42	74
Net Working Capital (NWC)	32	39	72
Net Nonoperating Expense (NNE)	0.82	2.19	0.99
Net Nonoperating Obligations (NNO)	47	48	-31
Total Depreciation and Amortization (D&A)	9.57	11	14
Debt-free, Cash-free Net Working Capital to Revenue	15.98%	17.35%	14.96%
Debt-free Net Working Capital to Revenue	16.66%	18.01%	28.52%
Net Working Capital to Revenue	15.61%	17.04%	27.62%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.52	$1.42	$1.66
Adjusted Weighted Average Basic Shares Outstanding	7.50M	7.55M	8.24M
Adjusted Diluted Earnings per Share	$1.50	$1.40	$1.63
Adjusted Weighted Average Diluted Shares Outstanding	7.59M	7.65M	8.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.55M	7.64M	9.13M
Normalized Net Operating Profit after Tax (NOPAT)	12	13	15
Normalized NOPAT Margin	5.95%	5.58%	5.64%
Pre Tax Income Margin	6.44%	5.85%	7.11%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	17.28	6.58	10.61
NOPAT to Interest Expense	15.06	5.33	7.98
EBIT Less CapEx to Interest Expense	4.89	2.69	3.37
NOPAT Less CapEx to Interest Expense	2.67	1.44	0.74
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	58.73%	4.18%	35.95%

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	3/25/2023	6/24/2023	9/23/2023	12/23/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.38%	12.01%	12.77%	11.07%	10.86%	11.28%	13.53%	14.25%	10.08%	8.00%	2.44%
EBITDA Growth	11.03%	7.28%	13.64%	21.10%	20.97%	-15.12%	36.91%	49.38%	23.28%	58.69%	-2.97%
EBIT Growth	-1.32%	-7.18%	28.09%	31.58%	32.71%	-45.23%	40.53%	54.72%	8.57%	107.03%	-22.37%
NOPAT Growth	-17.54%	-14.65%	37.93%	33.61%	13.28%	-65.94%	41.18%	48.79%	18.20%	250.76%	-53.00%
Net Income Growth	-16.70%	-21.82%	-1.72%	20.01%	-4.00%	-80.48%	109.12%	88.35%	49.47%	614.35%	-29.60%
EPS Growth	-18.37%	-22.50%	0.00%	20.00%	-5.00%	-80.65%	80.95%	68.75%	26.32%	483.33%	-34.21%
Operating Cash Flow Growth	-0.58%	-41.40%	79.25%	-43.21%	268.87%	164.29%	24.91%	92.44%	18.42%	-18.98%	15.40%
Free Cash Flow Firm Growth	-4,566.56%	30.27%	15.92%	65.75%	66.39%	-158.62%	-113.10%	-322.45%	-533.56%	-15.30%	-208.31%
Invested Capital Growth	42.28%	17.31%	18.19%	10.50%	11.81%	33.79%	31.59%	31.88%	54.98%	30.29%	69.34%
Revenue Q/Q Growth	-2.18%	3.25%	1.71%	8.13%	-2.37%	3.64%	3.76%	8.82%	-5.93%	1.68%	-1.58%
EBITDA Q/Q Growth	-20.10%	-3.65%	-3.29%	62.65%	-20.19%	-32.39%	55.98%	77.47%	-34.13%	-12.97%	-4.63%
EBIT Q/Q Growth	-30.39%	-10.41%	-7.74%	128.67%	-29.78%	-63.02%	136.70%	151.76%	-50.73%	-29.49%	-11.25%
NOPAT Q/Q Growth	-3.33%	-13.84%	-13.83%	86.14%	-18.04%	-74.09%	257.19%	96.17%	-34.89%	-23.11%	-52.14%
Net Income Q/Q Growth	0.79%	-23.27%	-32.07%	128.48%	-19.38%	-84.40%	627.83%	105.79%	-36.02%	-25.45%	-28.27%
EPS Q/Q Growth	0.00%	-22.50%	-32.26%	128.57%	-20.83%	-84.21%	533.33%	113.16%	-40.74%	-27.08%	-28.57%
Operating Cash Flow Q/Q Growth	-61.01%	56.24%	173.81%	-65.95%	153.23%	11.94%	29.41%	-47.54%	55.82%	-23.41%	84.32%
Free Cash Flow Firm Q/Q Growth	-38.10%	52.66%	-7.57%	51.30%	-35.55%	-264.19%	11.37%	3.45%	-103.29%	33.72%	-136.99%
Invested Capital Q/Q Growth	5.35%	1.34%	0.44%	3.05%	6.60%	21.26%	-1.21%	3.27%	25.27%	1.94%	28.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.34%	29.71%	28.57%	30.85%	30.88%	32.04%	32.13%	33.89%	33.96%	31.27%	29.48%
EBITDA Margin	11.14%	10.40%	9.88%	14.87%	12.16%	7.93%	11.92%	19.44%	13.61%	11.65%	11.29%
Operating Margin	6.59%	6.42%	5.51%	9.43%	7.66%	2.62%	6.59%	12.98%	7.64%	5.51%	3.15%
EBIT Margin	6.31%	5.47%	4.97%	10.50%	7.55%	2.69%	6.15%	14.22%	7.45%	5.16%	4.66%
Profit (Net Income) Margin	5.62%	4.18%	2.79%	5.89%	4.87%	0.73%	5.14%	9.72%	6.61%	4.84%	3.53%
Tax Burden Percent	89.10%	76.30%	75.38%	75.80%	78.39%	57.36%	78.39%	71.74%	84.32%	88.50%	75.33%
Interest Burden Percent	100.00%	100.00%	74.53%	74.05%	82.21%	47.40%	106.64%	95.25%	105.23%	105.99%	100.64%
Effective Tax Rate	10.90%	23.70%	24.62%	24.20%	21.61%	42.64%	21.61%	28.26%	15.68%	11.50%	24.67%
Return on Invested Capital (ROIC)	10.41%	8.11%	7.07%	11.76%	9.55%	2.19%	7.83%	14.16%	8.56%	6.02%	2.55%
ROIC Less NNEP Spread (ROIC-NNEP)	10.03%	7.20%	5.24%	10.11%	8.13%	1.25%	7.62%	17.62%	9.36%	5.89%	25.39%
Return on Net Nonoperating Assets (RNNOA)	4.39%	3.76%	2.51%	5.15%	3.94%	0.55%	0.42%	0.90%	0.68%	0.45%	0.34%
Return on Equity (ROE)	14.80%	11.87%	9.58%	16.91%	13.49%	2.74%	8.24%	15.05%	9.24%	6.47%	2.89%
Cash Return on Invested Capital (CROIC)	-25.27%	-7.55%	-7.77%	-0.79%	-2.25%	-21.98%	-19.71%	-18.92%	-35.45%	-18.30%	-45.27%
Operating Return on Assets (OROA)	8.53%	6.91%	6.36%	12.96%	9.27%	3.01%	6.56%	15.27%	7.51%	4.89%	3.80%
Return on Assets (ROA)	7.60%	5.27%	3.58%	7.28%	5.97%	0.82%	5.48%	10.43%	6.66%	4.59%	2.88%
Return on Common Equity (ROCE)	14.80%	11.87%	9.58%	16.91%	13.49%	2.74%	8.24%	15.05%	9.24%	6.47%	2.89%
Return on Equity Simple (ROE_SIMPLE)	12.02%	10.95%	10.58%	0.00%	9.54%	6.27%	4.77%	0.00%	5.76%	6.67%	6.03%
Net Operating Profit after Tax (NOPAT)	3.21	2.77	2.38	4.44	3.64	0.94	3.37	6.60	4.30	3.31	1.58
NOPAT Margin	5.87%	4.90%	4.15%	7.15%	6.00%	1.50%	5.17%	9.31%	6.45%	4.87%	2.37%
Net Nonoperating Expense Percent (NNEP)	0.38%	0.91%	1.83%	1.65%	1.42%	0.95%	0.21%	-3.47%	-0.80%	0.12%	-22.84%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	1.51%	-	-	-	0.49%
Cost of Revenue to Revenue	70.66%	70.29%	71.43%	69.15%	69.12%	67.96%	67.87%	66.11%	66.04%	68.73%	70.52%
SG&A Expenses to Revenue	12.10%	12.83%	11.57%	11.03%	12.54%	18.51%	14.00%	9.82%	14.62%	13.70%	14.17%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.75%	23.28%	23.06%	21.42%	23.22%	29.43%	25.54%	20.91%	26.32%	25.76%	26.33%
Earnings before Interest and Taxes (EBIT)	3.45	3.09	2.85	6.52	4.58	1.69	4.01	10	4.97	3.50	3.11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6.09	5.87	5.67	9.23	7.37	4.98	7.77	14	9.08	7.90	7.54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.19	5.56	5.55	6.59	6.02	5.28	4.35	4.37	4.17	4.13	3.47
Price to Tangible Book Value (P/TBV)	67.60	45.29	45.54	39.84	35.99	83.67	10.41	9.88	11.17	10.46	20.85
Price to Revenue (P/Rev)	2.19	2.35	2.36	2.85	2.82	3.01	3.79	3.79	4.12	4.11	3.58
Price to Earnings (P/E)	43.15	50.77	52.48	61.40	63.11	84.27	91.23	72.09	72.36	61.96	57.57
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.32%	1.97%	1.91%	1.63%	1.58%	1.19%	1.10%	1.39%	1.38%	1.61%	1.74%
Enterprise Value to Invested Capital (EV/IC)	3.67	3.96	4.04	4.78	4.54	4.11	4.89	4.91	4.42	4.40	3.18
Enterprise Value to Revenue (EV/Rev)	2.43	2.58	2.57	3.05	3.01	3.22	3.67	3.67	4.04	4.03	3.72
Enterprise Value to EBITDA (EV/EBITDA)	21.34	22.91	22.83	26.21	25.34	28.72	31.34	28.86	30.93	28.96	27.06
Enterprise Value to EBIT (EV/EBIT)	36.96	41.05	40.20	44.26	41.86	50.05	54.78	48.95	54.09	50.32	48.74
Enterprise Value to NOPAT (EV/NOPAT)	44.80	50.97	49.13	54.66	53.89	67.93	73.41	65.08	69.92	62.12	64.32
Enterprise Value to Operating Cash Flow (EV/OCF)	29.30	36.67	30.00	41.52	31.77	28.26	30.79	29.21	31.59	33.65	29.71
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.58	0.55	0.52	0.49	0.44	0.39	0.02	0.02	0.01	0.01	0.15
Long-Term Debt to Equity	0.55	0.53	0.49	0.47	0.42	0.37	0.01	0.01	0.00	0.00	0.14
Financial Leverage	0.44	0.52	0.48	0.51	0.48	0.44	0.05	0.05	0.07	0.08	0.01
Leverage Ratio	1.88	1.99	1.96	2.01	1.92	1.89	1.50	1.49	1.41	1.40	1.34
Compound Leverage Factor	1.88	1.99	1.46	1.49	1.58	0.89	1.60	1.42	1.49	1.49	1.34
Debt to Total Capital	36.64%	35.50%	34.04%	33.02%	30.40%	27.82%	2.12%	1.81%	1.35%	1.10%	12.97%
Short-Term Debt to Total Capital	1.54%	1.54%	1.54%	1.51%	1.43%	1.20%	1.04%	1.02%	0.89%	0.88%	0.75%
Long-Term Debt to Total Capital	35.09%	33.96%	32.50%	31.51%	28.97%	26.63%	1.08%	0.79%	0.46%	0.23%	12.23%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	63.36%	64.50%	65.96%	66.98%	69.60%	72.18%	97.88%	98.19%	98.65%	98.90%	87.03%
Debt to EBITDA	2.14	2.07	1.95	1.83	1.72	1.96	0.16	0.13	0.10	0.08	1.12
Net Debt to EBITDA	2.12	2.03	1.88	1.77	1.64	1.91	-1.04	-0.94	-0.55	-0.55	1.00
Long-Term Debt to EBITDA	2.05	1.98	1.86	1.75	1.64	1.87	0.08	0.06	0.04	0.02	1.06
Debt to NOPAT	4.50	4.60	4.19	3.81	3.66	4.63	0.38	0.28	0.23	0.17	2.66
Net Debt to NOPAT	4.46	4.52	4.05	3.70	3.49	4.52	-2.43	-2.12	-1.24	-1.19	2.37
Long-Term Debt to NOPAT	4.31	4.40	4.00	3.64	3.48	4.43	0.19	0.12	0.08	0.03	2.51
Altman Z-Score	4.94	5.20	5.36	6.12	6.29	5.57	10.71	11.17	12.15	13.66	6.77
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.48	2.52	2.42	2.39	2.68	2.32	3.37	3.14	2.96	3.59	2.42
Quick Ratio	1.62	1.66	1.58	1.65	1.90	1.64	2.70	2.49	2.23	2.77	1.80
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	-18	-20	-9.55	-13	-47	-42	-40	-82	-54	-129
Operating Cash Flow to CapEx	85.52%	134.51%	367.69%	131.39%	272.35%	315.13%	298.69%	136.98%	242.90%	172.64%	439.11%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-26.81	0.00	-15.90	-52.95	-515.64	0.00	-1,576.55	-714.94	-647.10
Operating Cash Flow to Interest Expense	0.00	0.00	11.96	0.00	9.26	9.48	134.78	0.00	171.62	89.93	63.31
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	8.70	0.00	5.86	6.47	89.65	0.00	100.96	37.84	48.89
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.35	1.26	1.28	1.23	1.23	1.12	1.07	1.07	1.01	0.95	0.82
Accounts Receivable Turnover	5.91	5.63	6.11	5.39	5.85	5.70	6.10	5.55	5.82	5.74	5.64
Inventory Turnover	11.35	11.48	10.31	10.95	10.99	10.38	10.39	10.23	10.68	11.64	12.32
Fixed Asset Turnover	8.58	8.58	8.61	8.31	8.24	7.66	7.65	7.63	6.98	6.51	6.21
Accounts Payable Turnover	0.00	12.59	11.82	10.80	0.00	12.90	13.63	12.84	14.44	14.22	13.41
Days Sales Outstanding (DSO)	61.80	64.86	59.71	67.67	62.44	64.05	59.86	65.75	62.72	63.58	64.69
Days Inventory Outstanding (DIO)	32.15	31.80	35.41	33.35	33.21	35.15	35.14	35.68	34.18	31.36	29.63
Days Payable Outstanding (DPO)	0.00	28.99	30.87	33.80	0.00	28.29	26.78	28.43	25.29	25.67	27.22
Cash Conversion Cycle (CCC)	93.95	67.68	64.25	67.23	95.65	70.91	68.21	73.01	71.62	69.27	67.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	140	142	143	147	157	190	188	194	243	248	318
Invested Capital Turnover	1.77	1.65	1.70	1.64	1.59	1.46	1.52	1.52	1.33	1.24	1.08
Increase / (Decrease) in Invested Capital	42	21	22	14	17	48	45	47	86	58	130
Enterprise Value (EV)	516	563	577	704	713	782	920	953	1,074	1,090	1,012
Market Capitalization	464	513	529	656	667	730	950	984	1,093	1,111	975
Book Value per Share	$11.87	$12.23	$12.61	$13.18	$14.49	$17.98	$24.75	$25.50	$28.72	$29.39	$30.55
Tangible Book Value per Share	$0.91	$1.50	$1.54	$2.18	$2.42	$1.14	$10.35	$11.28	$10.72	$11.62	$5.09
Total Capital	141	143	144	149	159	192	223	229	266	272	323
Total Debt	52	51	49	49	48	53	4.73	4.16	3.58	3.00	42
Total Long-Term Debt	50	49	47	47	46	51	2.41	1.82	1.22	0.61	39
Net Debt	51	50	48	48	46	52	-30	-31	-19	-21	37
Capital Expenditures (CapEx)	2.39	2.37	2.38	2.27	2.77	2.68	3.66	4.18	3.67	3.96	2.87
Debt-free, Cash-free Net Working Capital (DFCFNWC)	37	39	36	40	40	38	37	39	42	47	43
Debt-free Net Working Capital (DFNWC)	37	40	38	42	42	39	72	74	65	71	47
Net Working Capital (NWC)	35	38	36	39	40	37	69	72	62	69	45
Net Nonoperating Expense (NNE)	0.14	0.41	0.78	0.78	0.69	0.48	0.02	-0.29	-0.11	0.02	-0.78
Net Nonoperating Obligations (NNO)	51	50	48	48	46	52	-30	-31	-19	-21	37
Total Depreciation and Amortization (D&A)	2.64	2.78	2.82	2.71	2.79	3.29	3.76	3.70	4.11	4.40	4.43
Debt-free, Cash-free Net Working Capital to Revenue	17.37%	17.91%	16.15%	17.35%	16.91%	15.69%	14.59%	14.96%	15.87%	17.45%	15.67%
Debt-free Net Working Capital to Revenue	17.58%	18.33%	16.86%	18.01%	17.82%	16.20%	28.63%	28.52%	24.40%	26.25%	17.37%
Net Working Capital to Revenue	16.55%	17.31%	15.87%	17.04%	16.86%	15.26%	27.71%	27.62%	23.51%	25.37%	16.49%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.41	$0.31	$0.21	$0.49	$0.39	$0.06	$0.39	$0.82	$0.49	$0.36	$0.26
Adjusted Weighted Average Basic Shares Outstanding	7.54M	7.55M	7.56M	7.55M	7.62M	7.82M	8.62M	8.24M	9.06M	9.16M	9.23M
Adjusted Diluted Earnings per Share	$0.40	$0.31	$0.21	$0.48	$0.38	$0.06	$0.38	$0.81	$0.48	$0.35	$0.25
Adjusted Weighted Average Diluted Shares Outstanding	7.63M	7.65M	7.67M	7.65M	7.76M	7.95M	8.75M	8.35M	9.20M	9.28M	9.33M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.55M	7.56M	7.56M	7.64M	7.69M	8.83M	8.83M	9.13M	9.15M	9.20M	9.31M
Normalized Net Operating Profit after Tax (NOPAT)	3.21	2.77	2.38	4.44	3.64	0.94	3.37	6.60	4.30	3.31	1.58
Normalized NOPAT Margin	5.87%	4.90%	4.15%	7.15%	6.00%	1.50%	5.17%	9.31%	6.45%	4.87%	2.37%
Pre Tax Income Margin	6.31%	5.47%	3.70%	7.78%	6.21%	1.28%	6.55%	13.54%	7.84%	5.47%	4.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	3.90	0.00	5.62	1.90	49.44	0.00	95.54	46.09	15.62
NOPAT to Interest Expense	0.00	0.00	3.26	0.00	4.47	1.06	41.56	0.00	82.68	43.49	7.95
EBIT Less CapEx to Interest Expense	0.00	0.00	0.65	0.00	2.22	-1.11	4.32	0.00	24.88	-6.00	1.21
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.01	0.00	1.07	-1.95	-3.57	0.00	12.02	-8.60	-6.47
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	34.77%	14.56%	14.60%	4.18%	2.94%	26.04%	21.67%	35.95%	41.20%	31.70%	34.63%

Frequently Asked Questions About Transcat's Financials

When does Transcat's financial year end?

According to the most recent income statement we have on file, Transcat's fiscal year ends in March. Their fiscal year 2024 ended on March 30, 2024.

How has Transcat's net income changed over the last 2 years?

Transcat's net income appears to be on an upward trend, with a most recent value of $13.65 million in 2024, rising from $11.38 million in 2022. The previous period was $10.69 million in 2023. See where experts think Transcat is headed by visiting Transcat's forecast page.

What is Transcat's operating income?

Transcat's total operating income in 2024 was $19.78 million, based on the following breakdown:

Total Gross Profit: $83.81 million
Total Operating Expenses: $64.03 million

How has Transcat revenue changed over the last 2 years?

Over the last 2 years, Transcat's total revenue changed from $204.96 million in 2022 to $259.48 million in 2024, a change of 26.6%.

How much debt does Transcat have?

Transcat's total liabilities were at $62.38 million at the end of 2024, a 35.1% decrease from 2023, and a 31.9% decrease since 2022.

How much cash does Transcat have?

In the past 2 years, Transcat's cash and equivalents has ranged from $1.40 million in 2022 to $19.65 million in 2024, and is currently $19.65 million as of their latest financial filing in 2024.

How has Transcat's book value per share changed over the last 2 years?

Over the last 2 years, Transcat's book value per share changed from 11.46 in 2022 to 25.50 in 2024, a change of 122.6%.

Related Companies

This page (NASDAQ:TRNS) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Transcat (TRNS) Financials

Frequently Asked Questions About Transcat's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Transcat (TRNS) Financials

Annual Income Statements for Transcat

Quarterly Income Statements for Transcat

Annual Cash Flow Statements for Transcat

Quarterly Cash Flow Statements for Transcat

Annual Balance Sheets for Transcat

Quarterly Balance Sheets for Transcat

Annual Metrics and Ratios for Transcat

Quarterly Metrics and Ratios for Transcat

Frequently Asked Questions About Transcat's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools